New culprit in early Alzheimer’s: Blood–brain barrier blocks protective proteins
Researchers found that in a mouse model of early-stage Alzheimer's, the blood-brain barrier stopped importing protective proteins before it began to break down.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
A team led by neuroscientist Andrew Yang at the Gladstone Institute of Neurological Disease in San Francisco, California, catalogued 92 proteins that cross the blood-brain barrier into the brain, according to Nature. The work suggests the barrier does more than block substances: it actively transports proteins the brain needs, and a failure of that transport appears early in Alzheimer's disease.
Yang and his colleagues developed a technique to label a large array of proteins in the blood and track which ones can enter the brain. Of the 861 proteins they mapped, 92 crossed the barrier. Most were produced in distant organs, particularly the liver, Nature reported.
The team focused on apolipoprotein A1 (APOA1), a protein linked to potential protective effects against Alzheimer's disease. Once inside the brain, APOA1 stimulates brain cells called astrocytes to release cholesterol, which is important for maintaining the synapses through which neurons communicate. The researchers found two receptors for APOA1, SR-B1 and ABCA1, on the blood-brain barrier and on astrocytes, suggesting a route by which the protein moves from the blood into the specific brain cells that need it. When Yang's team blocked the ABCA1 receptor in laboratory-grown astrocytes, the protein no longer had the same cholesterol-regulating effects.
"The paradigm in the field has been that the blood-brain barrier is normally impermeable and then becomes leaky as a result of Alzheimer's disease," study co-author Andrew Yang said, according to Nature. His team's work instead suggests the barrier actively imports proteins the brain needs to function, and the loss of those proteins drives the dysfunction seen early in the disease.
Scientists have long known that the blood-brain barrier breaks down as Alzheimer's advances, letting harmful molecules leak into the brain. Yang's team found that a different problem emerges first. Using their labelling technique in a mouse model of Alzheimer's disease, the researchers found the barrier stopped importing protective proteins such as APOA1 before it began to break down. That disruption was accompanied by a loss of neuronal connections, behavioural changes and other early hallmarks of the disease.
The team then engineered mice with Alzheimer's to produce extra APOA1 in the liver. When more APOA1 crossed the blood-brain barrier and entered the brain, the mice showed fewer Alzheimer's-disease-related markers, including reduced fat build-up in astrocytes and lower levels of inflammatory molecules, Nature reported.
Synthesized by PULSE from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 6d ago.
Quick answers
How many proteins were found to cross the blood-brain barrier?
Of the 861 proteins the team mapped, 92 crossed the blood-brain barrier into the brain, according to Nature. Most of those 92 were produced in distant organs, particularly the liver.
What role does apolipoprotein A1 play in the brain?
According to Nature, once inside the brain, APOA1 stimulates brain cells called astrocytes to release cholesterol, which is important for maintaining the synapses through which neurons communicate. It has also been linked to potential protective effects against Alzheimer's disease.
What happened when mice with Alzheimer's produced extra APOA1 in the liver?
Nature reported that when more APOA1 crossed the blood-brain barrier and entered the brain, the mice showed fewer Alzheimer's-disease-related markers, including reduced fat build-up in astrocytes and lower levels of inflammatory molecules.
Coverage (11)
- NEWSLETTER: Blood-brain barrier discovery could lead to new Alzheimer's disease approach Reuters · 6d ago
- Health Rounds: Blood-brain barrier discovery could lead to new Alzheimer’s disease approach WHTC · 6d ago
- Health Rounds: Blood-brain barrier discovery could lead to new Alzheimer's disease approach TradingView · 6d ago
- Blood-Brain Barrier Protein Atlas Unlocks Alzheimer’s Neuroscience News · 6d ago
- Liver-derived protein helps protect brain cells and improves memory in Alzheimer's mice News-Medical · 6d ago
- New Culprit in Early Alzheimer’s: Blood–Brain Barrier Study JournalArta · 6d ago
- Scientists describe 92 proteins the barrier transports into the brain UA.NEWS · 6d ago
- First atlas tracks proteins that cross the blood-brain barrier Medical Xpress · 6d ago
- Study Rewrites The Rules of The Blood-Brain Barrier, Including Proteins That May Be Involved in Alzheimer's ScienceAlert · 6d ago
- The blood-brain barrier may contribute to cognitive function The Economist · 6d ago
- New culprit in early Alzheimer’s: Blood–brain barrier blocks protective proteins Nature · 6d ago
Topics
Related trends
A Plasma eMTBR-Tau Immunoassay for Detection of Advanced Insoluble Tau Pathology
A new plasma immunoassay measuring eMTBR-tau detects advanced insoluble tau pathology in Alzheimer's disease with accuracy comparable to mass spectrometry across four cohorts.
The first pill to slow Alzheimer’s could come from an unexpected place
An experimental oral Alzheimer's drug derived from an unexpected medical category shows varied results in phase 3 clinical trials.
The Largest Alzheimer's Genetics Study Yet Found 48 New Links. The Most Promising Clue Isn't About Memory
The largest Alzheimer's genetics study yet has uncovered 48 new links, highlighting how genetics and sleep interact.
David Cameron on Living With Brexit and Ending Alzheimer’s
Former UK Prime Minister David Cameron reveals his mother begged to die from dementia while urging billions in NHS Alzheimer's funding and 18-week diagnosis targets.
Stronger flu shot linked to nearly 55% lower Alzheimer's risk
New research covering nearly 200,000 adults links high-dose influenza vaccination to a 55% reduction in Alzheimer's disease risk, sparking debate over correlation versus causation.
Some people are resistant to dementia
Some people are resistant to dementia, sparking new research